RECRUITING

Thebaine Urine Testing

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To develop and validate a urine drug screen to detect thebaine.

Official Title

Clinical Feasibility of Thebaine Urine Mass Spectrometry Drug Testing

Quick Facts

Study Start:2025-05-07
Study Completion:2027-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07192887

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Male or female
  2. * Ages 18-65
  3. * Healthy
  1. * Allergy to poppy seeds, or any of the related food stuffs used in the study
  2. * Celiac disease or gluten sensitivity
  3. * Ongoing or opioid use in the past 6 months
  4. * History of renal or hepatic disease or dysfunction
  5. * Inability or unwillingness to give repeated urine specimens
  6. * Unwillingness to refrain from eating poppy seed-containing products during the two-day course of the study
  7. * Non-English speakers (due to study materials being in English)
  8. * BMI greater than 30
  9. * Antibiotic use in the previous 2 months
  10. * Recent ingestion of poppy seeds from the previous 7 days

Contacts and Locations

Study Contact

Charlotte Walter, MD
CONTACT
513-636-4408
charlotte.walter@cchmc.org

Principal Investigator

Charlotte Walter, MD
PRINCIPAL_INVESTIGATOR
Children's Hospital Medical Center, Cincinnati

Study Locations (Sites)

Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229
United States

Collaborators and Investigators

Sponsor: Children's Hospital Medical Center, Cincinnati

  • Charlotte Walter, MD, PRINCIPAL_INVESTIGATOR, Children's Hospital Medical Center, Cincinnati

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-07
Study Completion Date2027-03

Study Record Updates

Study Start Date2025-05-07
Study Completion Date2027-03

Terms related to this study

Additional Relevant MeSH Terms

  • Urine Specimen Collection